MCM
HUMA icon

MAI Capital Management’s Humacyte HUMA Stock Holding History

MAI Capital Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1K Buy
34,660
+28,828
+494% +$26.7K ﹤0.01% 2033
2026
Q1 		$3.54K Buy
5,832
+4,929
+546% +$5.12K ﹤0.01% 3683
2025
Q4 		$868 Buy
903
+250
+38% +$354 ﹤0.01% 3674
2025
Q3 		$1.14K Hold
653
– – ﹤0.01% 3469
2025
Q2 		$1.36K Hold
653
– – ﹤0.01% 3533
2025
Q1 		$1.11K Hold
653
– – ﹤0.01% 3101
2024
Q4 		$3.3K Buy
+653
New +$3.23K ﹤0.01% 2906

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

MAI Capital Management's HUMA Position: Q2 2026 in Review

MAI Capital Management increased its Humacyte (HUMA) stake by 494% in Q2 2026, buying an estimated $26.7K and bringing the position to 34,660 shares worth $27.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2033.

MAI Capital Management first reported a position in HUMA in Q4 2024 and has held it in 7 quarters since. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • MAI Capital Management held 34,660 shares of Humacyte worth $27.1K as of Q2 2026.
  • MAI Capital Management bought 28,828 Humacyte shares in Q2 2026, an estimated $26.7K.
  • Humacyte made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #2033 holding.
  • MAI Capital Management first reported a position in Humacyte in Q4 2024 and has held it in 7 quarters since.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.